ÇELİK, B. Et Al. 2015. Proteomics pattern of peritoneal sApo-2L but not CD200 (OX-2) as a possible screening biomarker for metastatic ovarian, endometrial and breast carcinoma. JOURNAL OF BUON , vol.20, no.1 , 280-286.

ÇELİK, B., Yalcin, A. D., Genc, G. E., & GÜMÜŞLÜ, S., (2015). Proteomics pattern of peritoneal sApo-2L but not CD200 (OX-2) as a possible screening biomarker for metastatic ovarian, endometrial and breast carcinoma. JOURNAL OF BUON , vol.20, no.1, 280-286.

ÇELİK, BETÜL Et Al. "Proteomics pattern of peritoneal sApo-2L but not CD200 (OX-2) as a possible screening biomarker for metastatic ovarian, endometrial and breast carcinoma," JOURNAL OF BUON , vol.20, no.1, 280-286, 2015

ÇELİK, BETÜL Et Al. "Proteomics pattern of peritoneal sApo-2L but not CD200 (OX-2) as a possible screening biomarker for metastatic ovarian, endometrial and breast carcinoma." JOURNAL OF BUON , vol.20, no.1, pp.280-286, 2015

ÇELİK, B. Et Al. (2015) . "Proteomics pattern of peritoneal sApo-2L but not CD200 (OX-2) as a possible screening biomarker for metastatic ovarian, endometrial and breast carcinoma." JOURNAL OF BUON , vol.20, no.1, pp.280-286.

@article{article, author={BETÜL ÇELİK Et Al. }, title={Proteomics pattern of peritoneal sApo-2L but not CD200 (OX-2) as a possible screening biomarker for metastatic ovarian, endometrial and breast carcinoma}, journal={JOURNAL OF BUON}, year=2015, pages={280-286} }